Hyperimmune Globulins Market Forecast: What to Expect by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Hyperimmune Globulins Market From 2025 To 2034?

The hyperimmune globulins market has experienced significant growth in recent years. It is projected to expand from $1.91 billion in 2024 to $2.06 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.5%. Historically, this expansion has been driven by increased government support and a rise in healthcare expenditures.

The hyperimmune globulins market is projected for substantial expansion in the coming years. By 2029, its valuation is anticipated to reach $2.71 billion, exhibiting a compound annual growth rate (CAGR) of 7.1%. This expansion throughout the forecast period stems from factors such as the rising occurrence of infectious diseases, heightened understanding of the advantages of hyperimmune globulin injections, increasing need for immunoglobulins, the growing incidence of alpha-1 antitrypsin deficiency, and an upward trend in immune deficiencies. Key developments anticipated during this timeframe involve technological advancements and innovation, increased spending on research and development, a rising need for passive immunity treatments, progress in plasma-derived therapies, and enhancements in manufacturing technologies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16448&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Hyperimmune Globulins Industry?

The hyperimmune globulin market is anticipated to expand due to the rising incidence of infectious diseases. These illnesses originate from harmful agents (pathogens) like viruses, bacteria, fungi, and parasites entering the body. Contributing factors to this growing prevalence include antimicrobial resistance, climate change, and population growth. Hyperimmune globulins are employed in infectious disease management to confer immediate passive immunity, delivering concentrated antibodies against specific pathogens and thereby assisting in the prevention or treatment of conditions such as rabies, hepatitis B, or tetanus. For instance, in April 2024, the Centers for Disease Control and Prevention, a US-based government agency, reported that chronic hepatitis B cases in the US rose by approximately 17%, from 14,229 in 2021 to 16,729 in 2022. Consequently, this upward trend in infectious diseases is fueling the expansion of the hyperimmune globulin market.

What Are The Major Segment Categories Driving The Hyperimmune Globulins Market Growth?

The hyperimmune globulinsmarket covered in this report is segmented –

1) By Type: Hepatitis B Hyperimmune Globulin; Rabies Hyperimmune Globulin; Tetanus Hyperimmune Globulin; Cytomegalovirus (CMV) Hyperimmune Globulin; Varicella-Zoster Virus (VZV) Hyperimmune Globulin; Respiratory Syncytial Virus (RSV) Hyperimmune Globulin; Other Types

2) By Route Of Administration: Intramuscular; Intravenous

3) By Application: Government Institution; Private Sector; Other Applications

Subsegments:

1) By Hepatitis B Hyperimmune Globulin: Intramuscular Hepatitis B Hyperimmune Globulin; Intravenous Hepatitis B Hyperimmune Globulin

2) By Rabies Hyperimmune Globulin: Rabies Immune Globulin (Human); Rabies Immune Globulin (Equine)

3) By Tetanus Hyperimmune Globulin: Tetanus Immune Globulin (Human); Tetanus Immune Globulin (Equine)

4) By Cytomegalovirus (Cmv) Hyperimmune Globulin: Cmv Immune Globulin For Organ Transplantation; Cmv Immune Globulin For Neonatal Infection

5) By Varicella-Zoster Virus (Vzv) Hyperimmune Globulin: Vzv Immune Globulin For Post-Exposure Prophylaxis; Vzv Immune Globulin For Immunocompromised Patients

6) By Respiratory Syncytial Virus (Rsv) Hyperimmune Globulin: Rsv Immune Globulin For Infants And Children; Rsv Immune Globulin For Adults With Respiratory Conditions

7) By Other Types: Diphtheria Hyperimmune Globulin; Botulism Hyperimmune Globulin; Other Specialized Hyperimmune Globulins

Who Are The Core Companies Influencing The Hyperimmune Globulins Market Landscape?

Major companies operating in the hyperimmune globulins market are F. Hoffmann-La Roche AG, Bayer AG, Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Ltd., Fresenius Kabi AG, Grifols SA, Octapharma AG, Shanghai RAAS Blood Products Co. Ltd., Emergent BioSolutions Inc., Kedrion Biopharma Inc., LFB SA, Hualan Biological Engineering Inc., FFF Enterprises Inc., Taibang Biologic Group, Bio Products Laboratory (BPL) Ltd., ADMA Biologics, Cangene Corporation, Kamada Ltd., Saol Therapeutics Inc., Omrix Biopharmaceuticals Ltd., Shire, Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd., BioCare Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/hyperimmune-globulins-global-market-report

What Are The Regional Market Dynamics Impacting The Hyperimmune Globulins Industry?

North America was the largest region in the hyperimmune globulins market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hyperimmune globulins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Hyperimmune Globulins Market Report:

https://www.thebusinessresearchcompany.com/customise?id=16448&type=smp

Browse Through More Reports Similar to the Global Hyperimmune Globulins Market 2025, By The Business Research Company

Immunoglobulins Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report

Hypersonic Missiles Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hypersonic-missiles-global-market-report

Hyperspectral Imaging System Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hyperspectral-imaging-system-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795